NCT07341490 CT-Angiography Versus Angiogram as Ancillary Tests in the Determination of Death by Neurologic Criteria
| NCT ID | NCT07341490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Stockholm |
| Condition | Infarction, Brain |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-01-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diagnostic performance of a novel protocol for computed tomography-angiography, as ancillary test in the determination of complete cerebral infarction, in comparison to four vessel angiography.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years or older * Ongoing critical care due to severe acute brain injury * Four vessel angiography necessary for the determination of complete cerebral infarction, according to Swedish legislation Exclusion Criteria: * Treatment with extracorporeal membrane oxygenation (ECMO) * Radiologic examination by computed tomography deemed too challenging due to respiratory or circulatory instability, as determined by responsible clinician
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07341490 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infarction, Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07341490 currently recruiting?
Yes, NCT07341490 is actively recruiting participants. Contact the research team at peter.rudberg@ki.se for enrollment information.
Where is the NCT07341490 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07341490 clinical trial?
NCT07341490 is sponsored by Region Stockholm. The trial plans to enroll 50 participants.